CVS Health Corporation (CVS)
| Market Cap | 80.64B |
| Revenue (ttm) | 384.33B |
| Net Income (ttm) | 4.53B |
| Shares Out | 1.27B |
| EPS (ttm) | 3.59 |
| PE Ratio | 17.71 |
| Forward PE | 9.75 |
| Dividend | $2.66 (4.18%) |
| Ex-Dividend Date | Jul 22, 2025 |
| Volume | 4,514,700 |
| Open | 63.63 |
| Previous Close | 63.52 |
| Day's Range | 62.55 - 63.83 |
| 52-Week Range | 43.56 - 72.51 |
| Beta | 0.59 |
| Analysts | Buy |
| Price Target | 75.50 (+18.75%) |
| Earnings Date | Jul 31, 2025 |
About SLRN
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for CVS stock is "Buy." The 12-month stock price target is $75.5, which is an increase of 18.75% from the latest price.
News
CVS Health Corporation (CVS) Q2 2025 Earnings Call Transcript
CVS Health Corporation (NYSE:CVS) Q2 2025 Earnings Call July 31, 2025 8:00 AM ET Company Participants a - Corporate Participant v - Corporate Participant Brian O. Newman - Executive VP & CFO J.
The worst is behind CVS expect tailwinds ahead, says Raymond James' John Ransom
John Ransom, Raymond James director of health care research, joins 'Money Movers' to discuss the health care sector as the group has lagged in 2025.
5 Dividend Stocks With Solid Returns And More Growth Ahead
Sector by sector, U.S. dividend stocks have outperformed so far this year, with historically dividend-friendly industries surpassing those with a more growth-oriented focus.
CVS Targets Strong Weight-Loss Drug Use as Revenues Tick Up
CVS is focusing heavily on technology-led care after posting solid Q2 earnings. “We are building momentum as we navigate what continues to be a dynamic and evolving environment,” Chief Executive David...
CVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks
CVS Health Corp CVS stock is trading higher on Thursday after the company reported better-than-expected Q2 earnings and raised its annual guidance.
CVS Health Stock Surges After Earnings Smash Forecasts. A Value Play Has Become a Rally.
The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.
Cramer's Mad Dash: CVS Health
Jim Cramer breaks down why he's keeping an eye on CVS Health.
CVS Health Stock Soars on Strong Results, Raised 2025 Profit Outlook
Shares of CVS Health (CVS) jumped in premarket trading Thursday after the health care giant posted better-than-expected second-quarter results and lifted its full-year adjusted profit forecast.
CVS stock jumps over 8% as turnaround fuels earnings beat, outlook raised
Shares of CVS Health jumped in premarket trading Thursday after the healthcare and pharmacy giant reported better-than-expected second-quarter earnings and lifted its full-year forecast, marking its t...
CVS beats estimates - hikes adjusted profit outlook on retail pharmacy and insurance unit strength
CNBC's Bertha Coombs joins 'Squawk Box' to break down the company's quarterly earnings results.
CVS Profits Eclipse $1 Billion As Aetna's Costs Begin To Stabilize
CVS Health Thursday reported $1 billion in second quarter net income as the company begins to get a handle on the health benefit costs that have dogged its Aetna health insurance business as well as i...
CVS's stock jumps, as profit beats by a wide margin and the outlook is raised
Shares of CVS Health Corp. CVS+3.83% shot up 8.9% in premarket trading Thursday, after the health and pharmacy services company beat profit second-quarter expectations by a wide margin and raised its ...
CVS second-quarter profit beats estimates, helped by medical cost oversight
CVS Health beat Wall Street estimates for second-quarter profit on Thursday, as tight oversight of higher medical costs led to improved performance for its Aetna health insurance business.
CVS beats estimates, hikes adjusted profit outlook on retail pharmacy and insurance unit strength
CVS Health reported second-quarter earnings and revenue that topped estimates and raised its adjusted profit outlook. CVS CEO David Joyner pointed to strength in its retail pharmacy business and some ...
CVS Health reported earnings that beat Wall Street's expectations and upgraded its projection for 2025, as its health-insurance business showed signs of recovery
The healthcare giant's results underscore a split among insurers between those that are struggling and those that are beginning to revive.
CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE
Financial Highlights Second quarter total revenues increased to $98.9 billion, up 8.4% compared to prior year Second quarter GAAP diluted EPS of $0.80 and Adjusted EPS of $1.81 Generated year-to-date ...
Top Wall Street Forecasters Revamp CVS Health Expectations Ahead Of Q2 Earnings
CVS Health Corporation CVS will release earnings results for the second quarter before the opening bell on Thursday, July 31.
63 July Fortune 500 Industry Leaders: 3 Ideal "Safer" Dividend Buys
Three Fortune 500 Industry Leaders—Energy Transfer, Verizon, and World Kinect—currently meet the ideal 'dogcatcher' standard for fair-priced, safer dividend stocks. Analyst projections suggest the top...
Buy CVS Stock Ahead of Its Upcoming Earnings?
CVS Health (NYSE:CVS) is scheduled to announce its earnings on Thursday, July 31, 2025. For event-driven traders, analyzing the stock's historical behavior around earnings releases can provide valuabl...
Aetna Launches New AI and Digital Tools to Improve Access and Care
Aetna Care Paths, a first-to-market care option available in the Aetna Health app, makes it easier and simpler for members to get the care they need AI enabled clinical solutions enhance the human tou...
Evercore ISI's Umer Raffat on finding value in the beaten-down health care sector
Umer Raffat, Evercore ISI senior analyst, joins 'The Exchange' to discuss if there's a turnaround coming for the health care sector.
Thousands of Americans are being forced to switch from Zepbound to Wegovy as a result of new coverage restrictions by CVS Caremark. ‘I just wish they would trust my doctor.
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced better weight-loss results and fewer side effects.
Visa, CVS, and 4 More Oversold Stocks Worth a Look Before Earnings
Stocks that have gained too much are more susceptible to big drops than companies that dropped heading into their results.
CVS Health opens new Workforce Innovation and Talent Center in Columbus
The new facility at Rosewind Community Center offers free workforce training and access to health services COLUMBUS, Ohio , July 23, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) announced today the op...